53rd week of 2020 patent applcation highlights part 27 |
Patent application number | Title | Published |
20200407437 | SPECIFIC BINDING MOLECULES - The present invention relates to the formation of multi-domain specific binding molecules comprising VNARs. Specific binding domains that bind to Tumour Necrosis Factor alpha (TNFα) are also provided. | 2020-12-31 |
20200407438 | MONOCLONAL ANTI-IL-1RACP ANTIBODIES - Monoclonal antibody that specifically binds IL-1RAcP, or an antigen binding fragment thereof, comprising: | 2020-12-31 |
20200407439 | CONDITIONALLY ACTIVE POLYPEPTIDES - A non-naturally occurring polypeptide or isolated polypeptide having a ratio of at least 1.3 of an activity in an assay at a first pH in the presence of at least one species having a molecular weight of less than 900 a.m.u. and a pKa up to 4 pH units away from said first pH, to an activity in an assay at a second pH in the presence of the same at least one species. The species has a pKa between said first pH and said second pH and can be a small molecule. Also disclosed are pharmaceutical formulations including the polypeptide and uses thereof. Methods of producing conditionally active polypeptides are also disclosed. | 2020-12-31 |
20200407440 | AMATOXIN ANTIBODY-DRUG CONJUGATES AND USES THEREOF - Amatoxins, as well as antibody-drug conjugates (ADCs) comprising an amatoxin are provided, as well as compositions and methods of using the same. The compositions and methods provided herein can also be used to prepare a patient for hematopoietic stem cell transplant therapy and to improve the engraftment of hematopoietic stem cell transplants by selectively depleting endogenous hematopoietic stem cells prior to the transplant procedure. Methods and compositions for the treatment of various hematopoietic diseases, metabolic disorders, cancers, and autoimmune diseases, as well as prevention of graft-versus-host-disease (GVHD), are provided. | 2020-12-31 |
20200407441 | Fusion Proteins Containing CD48 Antibodies and Cytokines - The present invention provides fusion proteins containing cytokines and novel CD47 antibodies or immunologically active fragments thereof, as well as pharmaceutical compositions containing such fusion proteins that can be used for treatment diseases mediated by CD47 or inhibition of phagocytosis or platelet aggregation. These fused proteins have low immunogenicity in humans and cause low or no level of red blood cell depletion or hemagglutination. | 2020-12-31 |
20200407442 | MONOCLONAL ANTIBODY AGAINST HUMAN LAG-3, METHOD FOR PREPARING THE SAME, AND USE THEREOF - Provided are novel fully human monoclonal antibodies that bind to human LAG-3. It also provides the methods of hybridoma generation using humanized rats, the nucleic acid molecules encoding the anti-LAG-3 antibodies, expression vectors and host cells used for the expression of anti-LAG-3 antibodies. The invention further provides the methods for validating the function of antibodies in vitro. The antibodies of invention provide a potent agent for the treatment of multiple cancers via modulating human immune function. | 2020-12-31 |
20200407443 | IMMUNOTOXINS, FORMULATIONS THEREOF AND THEIR USE IN MEDICINE - The present invention provides a composition comprising a first antibody molecule that specifically recognizes CD3 and a second antibody molecule that specifically recognizes CD7, for use in a method of treatment, or preventative treatment of viral infection or viral reactivation in a mammalian subject undergoing immunomodulatory treatment, wherein the first and second antibody molecules are each provided with a toxic moiety. Also provided is a method of treating a mammalian subject having, or being at risk of developing, chronic Graft versus Host disease (cGVHD). Also provided is a related pharmaceutical composition. | 2020-12-31 |
20200407444 | COMBINATION THERAPIES TARGETING PD-1, TIM-3, AND LAG-3 - This disclosure relates to combination therapies targeting two or all of PD-1, TIM-3, and LAG-3 using antibodies specific for these targets in patients who are in need of enhanced immunity. Also included in the disclosure are compositions useful in the therapies. The therapies are useful in treating diseases such as cancers. | 2020-12-31 |
20200407445 | ANTI-TIGIT ANTIBODIES - Anti-TIGIT antibodies and antigen binding fragments thereof that inhibit TIGIT-mediated signalling are provided, together with combinations comprising said antibodies or antigen binding fragments thereof and methods for their use. | 2020-12-31 |
20200407446 | BISPECIFIC ANTIBODY FOR ICOS AND PD-L1 - Multispecific antibody in mAb2 format, comprising an ICOS-binding Fab region and a PD-L1-binding Fcab region. Use of the multispecific antibody in immuno-oncology, including for treatment of solid tumours. Combination therapy including antibody to another immune checkpoint molecule such as PD-1 and CTLA-4, in addition to anti-ICOS and anti-PD-L1. | 2020-12-31 |
20200407447 | ANTAGONISTIC PD-1, PD-L1 AND LAG-3 BINDING PROTEINS - The present invention relates to antagonistic antigen binding proteins, a nucleic acid encoding the antagonistic binding protein, a recombinant expression vector comprising the nucleic acid molecule, a host cell comprising the vector, a method of making the antagonistic antigen binding protein, an antagonistic binding protein produced by the method and a pharmaceutical composition comprising the antagonistic binding protein, the nucleic acid or the vector. The present invention further relates to a kit comprising the pharmaceutical composition and use of the antagonistic binding protein in the treatment of cancer and/or chronic infectious diseases. | 2020-12-31 |
20200407448 | PD-1 AND PD-L1 BINDING AGENTS - The present invention relates, in part, to agents that bind PD-1 or PD-L1 and their use as diagnostic and therapeutic agents. The present invention further relates to pharmaceutical compositions comprising the PD-1 or PD-L1 binding agents and their use in the treatment of various diseases. | 2020-12-31 |
20200407449 | ANTI-VISTA ANTIBODY AND USE THEREOF - The present invention relates to an anti-VISTA antibody or an antigen binding fragment thereof, a nucleic acid coding for the same, a vector carrying the nucleic acid, a cell transformed with the vector, a method for preparing the antibody or an antigen binding fragment thereof, a composition for prevention or treatment of autoimmune disease, comprising the same antibody, and a composition for concurrent administration in combination with a PD-1 antibody or PD-L1 antibody. | 2020-12-31 |
20200407450 | USE OF A CEA CD3 BISPECIFIC ANTIBODY AND A PD-1 AXIS BINDING ANTAGONIST IN A DOSAGE REGIMEN TO TREAT CANCER - The present invention relates to the treatment of cancer, in particular to the treatment of cancer using a CEA CD3 bispecific antibody and a PD-1 axis binding antagonist. | 2020-12-31 |
20200407451 | A METHOD OF MODULATING CELL PROLIFERATION - The present disclosure relates to compositions and uses thereof for inhibiting epithelial cell proliferation by exposing an epithelial cell to an agent that inhibits P-selectin expression and/or activity. | 2020-12-31 |
20200407452 | METHODS FOR PROMOTING PANCREATIC ISLET CELL GROWTH - The present invention relates to methods of promoting growth of pancreatic islet cells, especially beta islet cells. In particular, the invention relates to methods of promoting growth of pancreatic islet cells by administration of HGF-MET agonists, such as MET agonist antibodies or fragments thereof. The invention further relates to HGF-MET agonists, such as MET agonist antibodies or fragments thereof, and pharmaceutical compositions comprising said agonists, for use in methods of the invention. | 2020-12-31 |
20200407453 | A RECOMBINANT PROTEIN COMPRISING A DOUBLE STRANDED RNA BINDING DOMAIN - The present invention relates to a recombinant protein with a nucleic acid binding domain. In particular, the present invention relates to a recombinant protein comprising a double stranded RNA (dsRNA) binding domain and a Cetuximab antibody; a complex further comprising dsRNA; a nucleic acid sequence; and a pharmaceutical composition comprising the recombinant protein or the complex of the invention and a pharmaceutically acceptable carrier. Further, the present invention relates to the recombinant protein, complex or pharmaceutical composition of the invention for use in the treatment of cancer, wherein said cancer is characterized by EGFR-overexpressing cells. | 2020-12-31 |
20200407454 | ANTI-CD25 ANTIBODY AGENTS - The present disclosure provides antibody sequences found in antibodies that bind to human CD25. In particular, the present disclosure provides sequences of anti-human CD25 antibodies, which do not block the binding of CD25 to IL-2 or IL-2 signalling. Antibodies and antigen-binding portions thereof including such sequences can be used in pharmaceutical composition and methods of treatment, in particular for treating cancer. | 2020-12-31 |
20200407455 | GENETICALLY MODIFIED CELLS AND METHOD FOR PRODUCING SAME - It is intended to produce a cell expressing a mutant chimeric antigen receptor (CAR) having excellent cytotoxicity to target cells. The present invention provides a genetically modified cell having introduced thereinto a polynucleotide encoding a chimeric antigen receptor (CAR) protein having a target binding domain that specifically binds to a human granulocyte-macrophage colony stimulating factor (GM-CSF) receptor, a transmembrane domain, and an intracellular signaling domain, wherein the tar get binding domain is a mutant having the substitution of glutamic acid at position 21 in the amino acid sequence shown in SEQ ID NO: 1 with another amino acid. | 2020-12-31 |
20200407456 | ANTIBODIES FOR T-CELL ACTIVATION - Antibodies that include an antigen binding region that binds to CD137 are provided herein. Also provided herein are bispecific antibodies that include a first antigen binding region that binds to CD137 and a second antigen binding region that binds to an immune checkpoint molecule, an immune stimulatory molecule, or a tumor antigen. Pharmaceutical compositions that include the antibodies and methods of treating cancer are provided. | 2020-12-31 |
20200407457 | ANTI-TRAILR2 ANTIBODY-TOXIN-CONJUGATE AND PHARMACEUTICAL USE THEREOF IN ANTI-TUMOR THERAPY - Provided is a broad-spectrum, efficient and anti-tumor anti-TRAILR2 antibody-toxin-conjugate (ADC, named Zapadcine-1(a, b, c, d) and Zapadcine-3(a, b, c, d, e)). Toxin with cytotoxic effect is linked to an anti-TRAILR2 humanized monoclonal antibody by means of a covalent bond by using disulfide bond bridging or conventional coupling technology and chemical linkers, so as to form an anti-TRAILR2 humanized antibody-toxin-conjugate. The ADC has the specificity of TRAILR2 positive tumors, and after conjugated to TRAILR2, the positive tumors can be endocytosed into lysosomes of tumor cells, and is degraded by means of proteases inside the lysosomes to release free micromolecule urotoxins, so that different TRAILR2 positive tumor cells are killed specifically, the tumor growth is suppressed, the tumor cells are even completely eliminated, and the tumor is cured. | 2020-12-31 |
20200407458 | ANTI CD30 CHIMERIC ANTIGEN RECEPTOR AND ITS USE - In a first aspect, the present disclosure relates to genetically modified T-cells having a chimeric antigen receptor for use in adoptive cell therapy for treating CD30+cancer in a subject need thereof. In particular, the present disclosure relates to a T-cell containing a specific chimeric antigen receptor being toxic to CD30+cancer cells while being non-toxic to CD30+non-cancer cells. In a further aspect, the present disclosure relates to a specific chimeric antigen receptor and the nucleic acid molecule encoding the receptor as well as vectors and cells containing the same. Finally, the present disclosure relates to the use of the chimeric antigen receptor for use in improving persistence and amplification of lymphocyte containing the same and the use of specific peptides for improving persistence and amplification of genetically modified lymphocytes expressing the same. | 2020-12-31 |
20200407459 | Anti-CD38 Antibodies for Treatment of Light Chain Amyloidosis and Other CD38-Positive Hematological Malignancies - The present invention relates to methods of treatment of light chain amyloidosis and other CD38-positive hematological malignancies with anti-CD38 antibodies. | 2020-12-31 |
20200407460 | HUMAN MESOTHELIN CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF - Provided are compositions and methods for treating diseases associated with expression of mesothelin. Also provided are a chimeric antigen receptor (CAR) specific to mesothelin, vectors encoding the same, and recombinant T cells comprising the mesothelin CAR. Further provided are methods of administering a genetically modified T cell expressing a CAR that comprises a mesothelin binding domain. | 2020-12-31 |
20200407461 | TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY - The present invention relates to Chimeric Antigen Receptors (CAR) that are recombinant chimeric proteins able to redirect immune cell specificity and reactivity toward selected membrane antigens, and more particularly in which extracellular ligand binding is a scFV derived from a 5T4 monoclonal antibody, conferring specific immunity against 5T4 positive cells. The engineered immune cells endowed with such CARs are particularly suited for treating lymphomas and leukemia, and for solid tumors such as colon, stomach, and ovarian tumors. | 2020-12-31 |
20200407462 | DIAGNOSTIC METHODS USING ANTI-MUC1* ANTIBODIES - The present application discloses a method of determining suitability of treating a patient suffering from cancer or metastasis of cancer characterized by aberrant expression of MUC1, with a MUC1* targeting therapeutic. | 2020-12-31 |
20200407463 | PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII - The inventors discovered that by administering a pharmaceutical composition comprising a bispecific antigen-binding molecule that recognizes blood coagulation factor IX and/or activated blood coagulation factor IX and blood coagulation factor X and/or activated blood coagulation factor X according to a given dosage regimen, diseases that develop and/or progress due to a decrease or deficiency in the activity of blood coagulation factor VIII and/or activated blood coagulation factor VIII can be prevented and/or treated more effectively. | 2020-12-31 |
20200407464 | GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES - The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention. | 2020-12-31 |
20200407465 | GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES - The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention. | 2020-12-31 |
20200407466 | GENETIC ENGINEERING OF NON-HUMAN ANIMALS FOR THE PRODUCTION OF CHIMERIC ANTIBODIES - The invention provides non-human cells and mammals having a genome encoding chimeric antibodies and methods of producing transgenic cells and mammals. Certain aspects of the invention include chimeric antibodies, humanized antibodies, pharmaceutical compositions and kits. Certain aspects of the invention also relate to diagnostic and treatment methods using the antibodies of the invention. | 2020-12-31 |
20200407467 | PROTEASE ACTIVITY PROFILING VIA PROGRAMMABLE PHAGE DISPLAY OF COMPREHENSIVE PROTEOME-SCALE PEPTIDE LIBRARIES - The present invention relates to the field of proteases. More specifically, the present invention provides compositions and methods useful for profiling protease activity using phage display. In one embodiment, a display vector useful for profiling protease activity comprises a nucleic acid sequence encoding (a) a peptide to be displayed on the surface of the vector; (b) a first affinity tag C-terminal to the peptide; and (c) a second affinity tag N-terminal to the peptide. The display vector can comprise a virus, bacteriophage, yeast, bacteria, retrovirus, ribosome or mRNA. In particular embodiments, the peptide comprises a human peptidome library peptide. | 2020-12-31 |
20200407468 | WATER-SOLUBLE POLYSACCHARIDE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR USES - A neutral salt consisting of a polyaminosaccharide cation and an anion, as well as a procedure for the preparation of the neutral salt and uses thereof as a biomaterial and as an ingredient in pharmaceutical compositions are disclosed. Indeed, said neutral salt has surprisingly exhibited high water-solubility and high purity, the preparation procedure having minimised the content of high-risk contaminants in the final product and reduced reaction and purification times. | 2020-12-31 |
20200407469 | IMPROVED PROCESS FOR PREPARING ALKALI METAL SALT OF CARBOXYALKYL ETHER OF TAMARIND GUM - The present disclosure relates to a process for preparing alkali metal salt of carboxyalkyl ether of tamarind gum with one or more improved properties like improved viscosities and electrolytic stability. Particularly the present disclosure provides a process for preparing alkali metal salt of carboxyalkyl ether of tamarind gum comprising:
| 2020-12-31 |
20200407470 | METHODS OF SYNTHESIS OF HOMOPOLYMERS AND NON-HOMOPOLYMERS COMPRISING REPEATING UNITS DERIVED FROM MONOMERS COMPRISING LACTAM AND ACRYLOYL MOIETIES IN AN AQUEOUS MEDIUM - The invention provides a method for preparation of homopolymers and non-homopolymers comprising polymerizing in an aqueous medium a monomer comprising at least one acryloyl moiety and at least one functionalized or unfunctionalized lactam moiety, and optionally at least one hydrophilic or hydrophobic comonomer, in the presence of at least one chain transfer agent and at least one non-radiation initiator. Exemplerary diblock polymers prepared by the method have the structure: | 2020-12-31 |
20200407471 | CARBAMATE FUNCTIONAL MONOMERS AND POLYMERS AND USE THEREOF - The present invention is directed to a compound of formula I, | 2020-12-31 |
20200407472 | System for Obtaining a Photopolymerized Prepolymer - A photopolymerized prepolymer manufacturing system can create material suitable for 3D printing buildings or building components. The system can include a conveyor, a prepolymerization chamber, and one or more processors. The prepolymerization chamber can have multiple prepolymerization stations arranged in sequence and can convert untreated material into photopolymerized prepolymer material as the conveyor moves the prepolymer past the prepolymerization chamber. The processor(s) can control operations of the conveyor, the prepolymerization chamber, or both, to alter operations in response to a detected system event. Each polymerization station can include a light source, such as an LED array, that irradiates material. Each light source can be in a lid of the prepolymerization station. When operation of one polymerization station is halted, such as for maintenance, then the system can increase the light source intensity of the remaining polymerization stations, slow the conveyor speed, or both. | 2020-12-31 |
20200407473 | AGED LANTHANIDE-BASED CATALYST SYSTEMS AND THEIR USE IN THE PREPARATION OF CIS-1,4-POLYDIENES - A method for preparing cis-1,4-polydienes, the method comprising the steps of preparing a preformed, active lanthanide-based catalyst, aging the active lanthanide-based catalyst for more than 5 days to thereby formed an aged catalyst, and introducing the aged catalyst and conjugated diene monomer to be polymerized to thereby form an active polymerization mixture in which the conjugated diene monomer is polymerized to form a polydiene having a reactive chain end. | 2020-12-31 |
20200407474 | ETHYLENE-PROPYLENE BRANCHED COPOLYMERS AS VISCOSITY MODIFIERS WITH ENHANCED FUEL ECONOMY - In some embodiments, ethylene-propylene branched copolymers are synthesized with pyridyldiamido catalysts and a chain transfer agent, and their performance as viscosity modifiers in oil are detailed. In some embodiments, the present disclosure provides for ethylene-propylene branched copolymers having a shear thinning onset of less than about 0.01 rad/s and an HTHS value of less than about 3.3. In some embodiments, the ethylene-propylene branched copolymer is used as a viscosity modifier in a lubricating composition and a fuel composition. | 2020-12-31 |
20200407475 | TUNABLE LINEAR FLUOROPOLYMERS - The present disclosure provides tunable fluoropolymers and methods for making them. | 2020-12-31 |
20200407476 | RADIATION-SENSITIVE RESIN COMPOSITION, PRODUCTION METHOD THEREOF, AND RESIST PATTERN-FORMING METHOD - An object of the present invention is to provide a radiation-sensitive resin composition being superior in each of an inhibitory ability of defects, LWR performance, and sensitivity. An aspect of the present invention is a radiation-sensitive resin composition containing: a polymer having a first structural unit represented by the following formula (1), and a second structural unit represented by the following formula (2) and having an acid-labile group; a first acid generating agent which generates a first acid upon irradiation with a radioactive ray; and a second acid generating agent which generates a second acid upon irradiation with a radioactive ray, wherein the first acid, to be generated from the first acid generating agent, disassociates the acid labile group in the polymer upon heating under a condition involving a temperature of no less than 80° C. and no greater than 140° C. for a time period of 1 minute, the second acid, to be generated from the second acid generating agent, does not substantially disassociate the acid-labile group under the condition, and a ratio (Mw/Mn) of a polystyrene-equivalent weight average molecular weight to a number average molecular weight as measured by gel permeation chromatography of the polymer is less than 1.5. | 2020-12-31 |
20200407477 | POLYMER, POSITIVE RESIST COMPOSITION, AND METHOD OF FORMING RESIST PATTERN - A polymer includes a monomer unit (A) represented by formula (I), shown below, and a monomer unit (B) represented by formula (II), shown below, and has a weight-average molecular weight of 30,000 or more. In formula (I), B is a bridged saturated hydrocarbon cyclic group that is optionally substituted and n is 0 or 1. In formula (II), R | 2020-12-31 |
20200407478 | METHOD FOR PREPARING GRAFT COPOLYMER AND THERMOPLASTIC RESIN MOLDED ARTICLE - The present invention relates to a method for preparing a graft copolymer including polymerizing a conjugated diene-based monomer to prepare a small-size conjugated diene-based polymer; enlarging the small-size conjugated diene-based polymer to prepare a large-size conjugated diene-based polymer; and polymerizing the small-size conjugated diene-based polymer, the large-size conjugated diene-based polymer, an aromatic vinyl-based monomer and a vinyl cyan-based monomer to prepare a graft copolymer, wherein a weight ratio of the small-size conjugated diene-based polymer and the large-size conjugated diene-based polymer is 10:90 to 40:60 in preparing the graft copolymer. | 2020-12-31 |
20200407479 | POLYETHER-BASED BLOCK COPOLYMERS HAVING HYDROPHOBIC DOMAINS - The invention relates to a polymerization method in which alkyl glycidyl ethers and epoxides, such as ethylene oxide, polypropylene oxide, 1-ethoxyethyl glycidyl ether and gycidol, are copolymerized and block copolymers are synthesized. The inventive methods include an initiator, oligomer blocks of 1 to 40 alkyl glycidyl ether units of type (I), (II) or (III), and 80 to 1000 epoxy units of large polyether blocks, such as polyethylene oxide (PEO), polypropylene oxide (PPO), polyethoxyethylene glycidyl ether (PEEGE), linear and branched polyglycidol (PG, hbPG) or random copolymers of two, three or four different epoxide units, such as ethylene oxide (EO), propylene oxide (PO), 1-ethoxyethyl glycidyl ether (EEGE) and/or glycidol. | 2020-12-31 |
20200407480 | AMPHIPHILIC BLOCK POLYMERS SOLUBLE IN STRONGLY SALINE MEDIUM - The present invention relates to the preparation of polymers that are of use in particular as a rheology agent, and are suitable for use in very concentrated saline media, which comprises a step of micellar radical polymerization in which are brought into contact, in an aqueous medium: —hydrophilic monomers; —hydrophobic monomers in the form of a micellar solution, containing micelles comprising these hydrophobic monomers; —a radical polymerization initiator; and —preferably an agent for controlling radical polymerization, wherein said micelles comprise at least one surfactant of amphoteric nature. The polymers obtained according to the invention are in particular of use for enhanced oil recovery. | 2020-12-31 |
20200407481 | TETRA-BLOCK COPOLYMER, AND POLYMER COMPOSITION, AND HOT-MELT STICKY ADHESIVE COMPOSITION USING THESE - A tetrablock copolymer having an aromatic vinyl block (A1), a conjugated diene block (B1), an aromatic vinyl block (A2), and a conjugated diene block (B2) is provided, wherein Mw(A2)/Mw(A1) is 1.2 to 5, Mw(A2) is 12,000 or more, Mw(B1)>Mw(B2), Mw(Total) is 50,000 to 400,000 where the weight average molecular weight of the aromatic vinyl block (A1) is defined as Mw(A1), the weight average molecular weight of the conjugated diene block (B1) is defined as Mw(B1), the weight average molecular weight of the aromatic vinyl block (A2) is defined as Mw(A2), the weight average molecular weight of the conjugated diene block (B2) is defined as Mw(B2), and the weight average molecular weight of the tetrablock copolymer as a whole is defined as Mw(Total), and the content of aromatic vinyl monomer units is 10 to 30% by weight. | 2020-12-31 |
20200407482 | METHODS FOR MAKING RECYCLABLE AND DEPOLYMERIZABLE POLYMER NETWORK MATERIALS VIA THIOURETHANE DYNAMIC CHEMISTRY - Polythiourethane polymer networks that can be processed and/or recycled are provided. Also provided are methods of forming the polythiourethane polymer networks using excess thiol and/or a dual catalyst system and methods for reprocessing and recycling the polyurethane polymer networks. The polythiourethane polymer networks are based on thiourethane dynamic chemistry. | 2020-12-31 |
20200407483 | A BLOCKED ISOCYANATE COMPOSITION - This invention generally provides blocked isocyanate compositions and more specially blocked isocyanate compositions useful in aminoplastic resins, phenoplastic resins or latex resins for composite wood products, wherein the blocked isocyanate composition is obtained by adding alkylene carbonate to a blocked isocyanate (A), wherein the blocked isocyanate (A) is obtained by reacting a secondary amine (a1) with a reaction product (a2) of a polyfunctional isocyanate and a monofunctional hydroxyl containing compound, wherein the monofunctional hydroxyl containing compound is a polyethylene oxide polymer with terminal hydroxyl group, polyoxyethylene-polyoxypropylene monols or a mixture thereof, wherein the portion of blocked isocyanate (A) by weight percentage of the blocked isocyanate composition is between 50 and 90, preferably between 60 and 80. The compositions are stable at room temperature when mixed with active hydrogen containing compounds. The composition has low visicosity and after de-block has the potential to reduce free formaldehyde levels in formaldehyde containing resins. | 2020-12-31 |
20200407484 | METHOD AND SYSTEM FOR PRODUCING A POLYURETHANE POLYMER BY MEANS OF A SUPPORTED CATALYST - A process for preparing a polyurethane polymer comprises the step of:
| 2020-12-31 |
20200407485 | POLYURETHANE FOAMS BASED ON POLYETHERCARBONATE POLYOLS - The invention relates to a method for producing polyurethane foams by reacting the following components A a polyol component containing A1 40 to 100 parts by weight of polyether carbonate polyol with a hydroxyl number according to DIN 53240-1 Jun. 2013 of 20 mg KOH/g to 120 mg KOH/g, A2 0 to 60 parts by weight of polyether polyol with a hydroxyl number according to DIN 53240-1 Jun. 2013 of 20 mg KOH/g to 250 mg KOH/g and an ethylene oxide content of 0 to 60 wt. %, wherein polyether polyol A2 is free from carbonate units, B B1 a catalyst and B2 optionally auxiliary and additional materials, C water and/or physical blowing agents with D di- and/or polyisocyanates, wherein the production occurs at a characteristic value of 90 to 120, characterised in that the component A contains a component A5 of 0.05 to 10.00 parts by weight of polyester polyol, in relation to the sum of the parts by weight of the components A1+A2=100 parts by weight, said polyester polyol containing units derived from malonic acid. | 2020-12-31 |
20200407486 | RESIN COMPOSITION AND CURED PRODUCT OF SAME, ADHESIVE FOR ELECTRONIC COMPONENT, SEMICONDUCTOR DEVICE, AND ELECTRONIC COMPONENT - An object is to provide a resin composition which is excellent in resistance to impact when dropped after curing and which is also excellent in solvent resistance, a cured product thereof, an adhesive agent for electronic components including this resin composition, a semiconductor device and an electronic component including the cured product of this resin composition. This resin composition includes (A) a hydrogenated bisphenol A-type epoxy resin, (B) a multifunctional thiol resin, and (C) a curing catalyst. The cured product of the resin composition has an elastic modulus of 0.5 GPa or more at 50° C. The resin co sition preferably includes a glycoluril compound as the component (B). | 2020-12-31 |
20200407487 | Base Proliferating Agent, and Base-Reactive Resin Composition Containing Said Base Proliferating Agent - This base proliferating agent is represented by formula (1) or (2), where, in formulae (1) and (2), R1, R2, and R3 independently represent a hydrogen atom or a substituent and n independently represents an integer from 1 to 4. A base-reactive resin composition can include this base proliferating agent and a base-reactive compound. | 2020-12-31 |
20200407488 | FLOW CONTROLLED SYNTHESIS OF BOTTLEBRUSH MACROMOLECULES - Shape, size and composition are nature's most fundamental design features, enabling highly complex functionalities. Despite recent advances, the independent control of shape, size and chemistry of macromolecules remains a synthetic challenge. Herein reported is a scalable methodology to produce large well-defined macromolecules with programmable shape, size and chemistry that combines reactor engineering principles and controlled polymerizations. Specifically, bottlebrush polymers with conical, ellipsoidal and concave architectures are synthesized using two orthogonal polymerizations. The chemical versatility is highlighted by the synthesis of a compositional asymmetric cone. The strong agreement between predictions and experiments validate the precision that this methodology offers. | 2020-12-31 |
20200407489 | Gold Catalyzed Polymerization Reactions of Unsaturated Substrates - The present invention provides novel methods and processes for polymerizing unsaturated substrates, such as alkyne bearing monomers, with arenes. The polymerizations are catalyzed by gold (Au) catalysts/complexes and/or other cocatalysts. The invention further provides novel structurally complex polymers prepared in high yield via an intermolecular polyhydroarylation mechanism. Such resulting products comprise oligomeric and polymeric materials with novel molecular architectures and microstructures, which subsequently impart unique properties. The invention includes both the synthesis methods and processes and the resulting compounds and compositions of matter. | 2020-12-31 |
20200407490 | SYSTEMS AND METHODS FOR PRODUCTION OF ARTIFICIAL EUMELANIN - “Black” photoactive materials that comprise synthetic eumelanin polymers are provided, as are methods of making and using the polymers. The synthetic eumelanin polymers are made from the plant oil vanillin, and exhibit defined structural and chemical characteristics (e.g. homogeneity, solubility, etc.) that make them suitable for use in devices that require photoactive materials, such as solar cells. | 2020-12-31 |
20200407491 | Semiconductor Compound, Use Thereof and Hydrogen Production System - The present disclosure provides a semiconductor compound, which includes a metal complex unit and a conjugate unit. The metal complex unit includes a coordination center and a plurality of ligands. The coordination center is a metal ion or a metal atom, and the ligands are linked with the coordination center. The conjugate unit is linked with the metal complex unit by covalent bond. | 2020-12-31 |
20200407492 | Bio-Based Polyethylene Terephthalate Polymer and Method of Making Same - A bio-based polyethylene terephthalate polymer comprising from about 25 to about 75 weight percent of a terephthalate component and from about 20 to about 50 weight percent of a diol component, wherein at least about one weight percent of at least one of the terephthalate and/or the diol component is derived from at least one bio-based material. A method of producing a bio-based polyethylene terephthalate polymer comprising obtaining a diol component comprising ethylene glycol, obtaining a terephthalate component comprising terephthalic acid, wherein at least one of the diol component and/or the diol component is derived from at least one bio-based material, and reacting the diol component and the terephthalate component to form a bio-based polyethylene terephthalate polymer comprising from about 25 to about 75 weight percent of the terephthalate component and from about 20 to about 50 weight percent of the diol component. | 2020-12-31 |
20200407493 | POLYESTER RESIN - A polyester resin including: structural unit (A) represented by a specific formula; structural unit (B) derived from an aliphatic diol having 3 to 8 carbon atoms (provided that the structural unit (A) is excluded); and at least one structural unit (C) selected from the group consisting of structural unit (c1) derived from a trivalent or higher-valent acid component and structural unit (c2) derived from a trihydric or higher-hydric alcohol component, the polyester resin including the structural unit (B) in an amount of 20 molar parts or more with respect to 100 molar parts of all the structural units derived from acid components. | 2020-12-31 |
20200407494 | Renewably Sourced Soil Release Polyesters - A renewably sourced soil release polyester | 2020-12-31 |
20200407495 | RADIATION CURABLE COMPOSITIONS - The present invention relates to a radiation curable composition comprising: (I) A radiation curable component comprising a compound having at least one ethylenically unsaturated group and (II) A chlorinated polyester component that is prepared from (A) A polyol component which is substantially free of any Bisphenol A derivative compound and which is substantially free of any cyclic ether polyol compound, said polyol component comprising a polyol compound (Ai) which is cyclic and which has at least two hydroxyl groups, and (B) A polycarboxylic acid component comprising a compound (Bi) having at least one chlorine group and at least two carboxyl groups, (C) optionally at least one monoalcohol compound, (D) optionally at least one monocarboxylic acid compound, (III) optionally at least one polycarboxylic acid compound substantially free of chlorine groups. | 2020-12-31 |
20200407496 | RING-OPENING POLYMERIZATIONS USING A FLOW REACTOR - Techniques regarding the synthesis of polyesters and/or polycarbonates through one or more ring-opening polymerizations conducted within a flow reactor and facilitated by a urea anion catalyst and/or a thiourea catalyst are provided. For example, one or more embodiments can comprise a method, which can comprise polymerizing, via a ring-opening polymerization within a flow reactor, a cyclic monomer in the presence an organocatalyst comprising a urea anion. | 2020-12-31 |
20200407497 | NOVEL MACROINITIATOR, PRODUCTION METHOD THEREOF AND METHOD FOR PRODUCING BLOCK COPOLYMER - Provided is an aliphatic polycarbonate applicable to the production of a block copolymer by radical polymerization. The aliphatic polycarbonate is represented by formula (1): | 2020-12-31 |
20200407498 | POLYCARBONATE HAVING ELECTRO-OPTIC EFFECT, METHOD FOR PRODUCING SAME, AND LIGHT CONTROL ELEMENT WHICH USES SAID POLYCARBONATE - The purpose of the present invention is to provide: a novel polymer which has an electro-optical effect; a method for producing such a polymer; and a light control element which uses such a polymer. The present invention relates to a non-crosslinkable polycarbonate which contains a moiety that has electro-optical characteristics. The present invention also relates to a method for producing a polycarbonate, which comprises a step for reacting a bisphenol compound, a diol compound that has electro-optical characteristics, and a phosgene in the presence of an acid binding agent and solvent. The present invention also relates to a light control element which comprises such polycarbonate. | 2020-12-31 |
20200407499 | POLYCARBONATE-POLYORGANOSILOXANE COPOLYMER - Provided is a polycarbonate-polyorganosiloxane copolymer (A), including: a polycarbonate block (A-1) formed of a repeating unit having a specific structure; and a polyorganosiloxane block (A-2) containing a repeating unit having a specific structure, wherein the polycarbonate-polyorganosiloxane copolymer satisfies the following requirements (1) to (3): (1) the content of the polyorganosiloxane block (A-2) in the polycarbonate-polyorganosiloxane copolymer (A) is from more than 40 mass % to 70 mass % or less; (2) the polycarbonate-polyorganosiloxane copolymer has a viscosity-average molecular weight of from 10,000 or more to 23,000 or less; and (3) the polycarbonate-polyorganosiloxane copolymer includes a specific polycarbonate block as the polycarbonate block (A-1). | 2020-12-31 |
20200407500 | Flame retardant soft ether foams - The present invention concerns a method for producing poly(oxyalkylene) polyols started with phosphorus-containing compounds, which have an inner block containing high amounts of EO, as well as the poly(oxyalkylene) polyols obtainable in this manner. Furthermore, the present invention comprises a method for producing polyurethane foams, preferably flexible polyurethane foams, by reacting an isocyanate component with a component reactive to isocyanates, which comprises at least one poly(oxyalkylene) polyol started with phosphorus-containing compounds with an inner block containing high amounts of EO, the polyurethane foams produced by the inventive method and their application. | 2020-12-31 |
20200407501 | POLYAMIDE BLOCK COPOLYMER AND POLYAMIDE FILM INCLUDING THE SAME - The present disclosure relates to a polyamide block copolymer and a polyamide film including the same. | 2020-12-31 |
20200407502 | CATIONIC POLYMERS WITH D-FRUCTOSE SUBSTITUENTS - The invention relates to new cationic polymers conjugated with D-fructose, as a result of which they can selectively interact with specific structure elements on cell surfaces. The problem was that of creating novel, biocompatible, easy-to-produce, D-fructose-conjugated cationic polymers that have a higher selectivity with respect to certain cell types. To solve this problem, the invention proposes cationic polymers with covalently bonded D-fructose of general formula (I) with the following components: a) cationic polymer: macromolecular compounds of n repeat units with one or more positive charges; b) linker: a unit that links the cationic polymer with D-fructose or derivatives of D-fructose by means of any alkyl or aryl group, any alkenyl or alkinyl group, an ether, thioether or amine, an ester, amide or other carboxylic acid derivative, a heterocycle (e.g. triazole or m maleimide), a disulphide, an imine or an imide; c) D-fructose: one or more D-fructoses or D-fructose derivatives in an open-chain, furanoid or pyranoid structure, not glycosidically linked via one of the five possible carbon atoms (1, 3, 4, 5, 6). | 2020-12-31 |
20200407503 | UNIFORM SEQUENCE-DEFINED POLYURETHANES AND USES THEREOF AS MOLECULAR LABELS - Some embodiments are directed to sequence-defined polyurethanes and methods of making and using same. | 2020-12-31 |
20200407504 | POLYAMIDE-IMIDE FILM AND PROCESS FOR PREPARING THE SAME - Embodiments provide a polyamide-imide polymer film, which comprises a polyamide-imide polymer formed by polymerizing a diamine compound, a dianhydride compound, and a dicarbonyl compound; and silica particles, wherein the number of aggregates having an average diameter of 150 to 200 nm observed in a cross-section cut in the thickness direction of the polyamide-imide film is less than 0.5/μm | 2020-12-31 |
20200407505 | POLYIMIDE FILM FOR GRAPHITE SHEET HAVING IMPROVED THERMAL CONDUCTIVITY, METHOD FOR MANUFACTURING SAME, AND GRAPHITE SHEET MANUFACTURED USING SAME - The present invention provides: a method for manufacturing a polyimide film for a graphite sheet having improved thermal conductivity; and the polyimide film. The present invention also provides a graphite sheet having excellent thermal conductivity, which is manufactured using the polyimide film. | 2020-12-31 |
20200407506 | POLYAMIDE-IMIDE FILM, PREPARATION METHOD THEREOF, AND COVER WINDOW COMPRISING SAME - Embodiments relate to a polyamide-imide film that maintains its mechanical properties at least at a certain level under the conditions of high temperatures and low temperatures and is excellent in transparency and folding characteristics, a process for preparing the same, and a cover window comprising the same. The polyamide-imide film comprises a polyamide-imide polymer and has an MO | 2020-12-31 |
20200407507 | POLYMER FILM, FRONT PLATE AND DISPLAY DEVICE COMPRISING SAME - Embodiments relate to a polymer film for a display that maintains a clean appearance and transparency and is excellent in antiblocking properties by securing a certain range of optical slip index (OS), a process for preparing the same, and a front panel and a display device comprising the same. The polymer film comprises a polymer resin selected from the group consisting of a polyamide-based resin and a polyimide-based resin and a filler and has an optical slip index (0.5) of less than 0.5. | 2020-12-31 |
20200407508 | METHOD FOR PRODUCING FIBERS, FILMS AND MOLDINGS OF A POLYBENZAZOLE POLYMER (P) - A method for producing films, fibers, and moldings of a polybenzazole polymer (P) by reacting at temperatures of 0 to 120° C. a mixture including (a) aromatic dicarboxylic compound(s) (I): | 2020-12-31 |
20200407509 | Method for Forming a Polyarylene Sulfide - A method for forming a polyarylene sulfide with a relatively low content of volatile malodorous compounds is provided. More particularly, such low compound levels may be achieved by selectively controlling the manner in which the polyarylene sulfide is washed after it is formed. | 2020-12-31 |
20200407510 | POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM PREPARED THEREFROM - The present invention relates to a positive-type photosensitive resin composition and a cured film prepared therefrom. The positive-type photosensitive resin composition introduces a multifunctional monomer into a positive-type photosensitive resin composition comprising a mixed binder in which a siloxane copolymer is added to an acrylic copolymer, whereby the penetration of a developer into the binder can be facilitated at the time of development of a pre-baked film to increase the solubility in the developer, thereby further enhancing the pattern developability and sensitivity. Further, a cured film prepared from the composition has excellent appearance characteristics without a rough surface of the film and a scum or the like at the bottom of the film during development. | 2020-12-31 |
20200407511 | MODIFIED SILOXANE RESIN, MODIFIED SILOXANE RESIN CROSSLINKED PRODUCT, AND MANUFACTURING METHOD FOR RESIN CROSSLINKED PRODUCT - The present invention relates to a modified siloxane resin, a crosslinked modified siloxane resin, and a method for preparing the crosslinked resin. More specifically, the present invention relates to a modified siloxane resin, a crosslinked modified siloxane resin with excellent superhydrophobicity obtained by dual curing of the resin, and a method for preparing the crosslinked resin. The use of the modified siloxane resin according to the present invention allows the crosslinked modified siloxane resin to have excellent superhydrophobicity and high hardness. The water repellency of the crosslinked resin can be appropriately controlled by varying the amount of the siloxane resin mixed. | 2020-12-31 |
20200407512 | POLYOLEFIN-POLYDIORGANOSILOXANE BLOCK COPOLYMER AND METHOD FOR THE SYNTHESIS THEREOF - A polyolefin-polydiorganosiloxane block copolymer may be prepared by Piers-Rubinsztajn reaction. | 2020-12-31 |
20200407513 | USE OF A POLYMERIC POLYPHOSPHITE AS A POLYMER PROCESSING AID - The invention pertains generally to a polymer composition comprising a certain secondary polymeric polyphosphite anti-oxidant, that can also act as a polymer processing aid alone or in combination with another polymer processing aid. | 2020-12-31 |
20200407514 | FACTORS CONTROLLING DRUG RELEASE IN CROSS-LINKED POLY(VALEROLACTONE) BASED MATRICES - The present disclosure relates to controlling drug release in cross-linked poly(valerolactone) based matrices. In one aspect, the compounds or pharmaceutically acceptable salts thereof include a poly(valerolactone)-co-poly(allylvalerolactone)-co-polyethylene glycol (PEG) copolymer. In some embodiments, at least a portion of allylvalerolactone residues within the copolymer are crosslinked with a crosslinker. In some embodiments, the compound has a polydispersity index of less than or equal to 1.5. In one aspect, a method is described herein, comprising: (a) polymerizing valerolactone residues, allylvalerolactone, and polyethylene glycol residues in the presence of a non-metal catalyst via a ring opening polymerization to produce a poly(valerolactone)-co-poly(allylvalerolactone)-co-polyethylene glycol copolymer; (b) crosslinking the poly(valerolactone)-co-poly(allylvalerolactone)-co-polyethylene glycol copolymer with a crosslinker; and (c) loading a drug into the crosslinked copolymer. In some embodiments, the compound can comprise amorphous networks. In some embodiments, the compound can include semi-crystalline networks. | 2020-12-31 |
20200407515 | GEL HAVING INTERPENETRATING NETWORK - The present invention provides a gel having an interpenetrating network formed from a first network structure and a second network structure, the first network structure being composed of a first crosslinked polymer formed from at least one noncrosslinkable compound selected from the group consisting of a compound represented by the following formula (I) and a compound represented by the following formula (II), and at least one crosslinkable compound selected from the group consisting of a compound represented by the following formula (III) and a compound represented by the following formula (IV), and the second network structure being composed of a second crosslinked polymer having at least one selected from the group consisting of an acidic dissociative group, an acidic dissociative group in a salt form, and a derivative group of an acidic dissociative group: | 2020-12-31 |
20200407516 | Preparation Method of Cross-Linked Sodium Hyaluronate Gel - A preparation method of a cross-linked sodium hyaluronate gel is disclosed, which including: preparing an alkaline aqueous solution of hyaluronic acid: formulating a sodium hyaluronate alkali liquor with the concentration of 10-30% g/ml; and carrying out a cross-linking reaction: the cross-linking agent used in the cross-linking reaction being divinyl sulfone or 1,4-butanediol diglycidyl ether, the cross-linking reaction being carried out in an alkaline aqueous solution of hyaluronic acid, the reaction temperature of the cross-linking reaction being 20-40° C., the time of the cross-linking reaction being 4-8 h, and the like. The method of this invention has many advantages, such as easily available raw materials, mild reaction conditions, high cross-linking efficiency, simple process and post-treatment, and easy operation. The obtained cross-linked sodium hyaluronate has a three-dimensional network structure by the crosslinking reaction with good mechanical properties, and can be used as a good drug carrier and a tissue engineering scaffold material. | 2020-12-31 |
20200407517 | REINFORCED POLYCARBONATE COMPOSITIONS WITH IMPROVED HEAT RESISTANCE - A reinforced polycarbonate composition includes 30-60 wt % of a homopolycarbonate; 5-30 wt % of a poly(carbonate-siloxane); 10-40 wt % of a high heat polycarbonate having a glass transition temperature of 170° C. or higher determined per ASTM D3418 with a 20° C./min heating rate; 1-10 wt % of a phosphorous-containing flame retardant present in amount effective to provide 0.1-1.5 wt % phosphorous; 0.01-0.5 wt % of an anti-drip agent; 5-30 wt % of a reinforcing fiber; and optionally, up to 10 wt % of an additive composition, wherein each amount is based on the total weight of the reinforced polycarbonate composition, which sums to 100 wt %. A molded sample of the polycarbonate composition has a heat deflection temperature greater than 115° C., preferably greater than 125° C., more preferably greater than 130° C., or a flame test rating of V1, preferably V0 as measured according to UL-94 at a thickness of 0.8 millimeter, or at a thickness of 0.6 mm, or at a thickness of 0.4 mm. | 2020-12-31 |
20200407518 | FIBER-REINFORCED COMPOSITE MATERIAL AND METHOD FOR MANUFACTURING SAME - An object of the present invention is to develop and provide a fiber-reinforced composite material having an “elongation” feature in addition to a high strength and a high elastic modulus. Further, an object of the present invention is to address problems of brittleness and peeling in the conventional fiber-reinforced composite materials. A fiber-reinforced composite material containing the bagworm silk thread as reinforcing fibers is provided. | 2020-12-31 |
20200407519 | POLYMER FILM AND PREPARATION METHOD THEREOF - The polymer film according to an embodiment comprises at least one polymer resin selected from the group consisting of a polyamide-based resin, a polyimide-based resin, and a polyamide-imide-based resin, and has a haze of 0.6% or less and an in-plane retardation within a specific range for each wavelength band in the visible light region. | 2020-12-31 |
20200407520 | POLYIMIDE-BASED FILM AND PREPARATION METHOD THEREOF - The embodiments relate to a polyimide-based film, which comprises a first side and a second side opposite to the first side, wherein the modulus asymmetry (MA) according to Equation 1 is 0.03 to 0.2, a process for preparing the same, and a display device comprising the same. | 2020-12-31 |
20200407521 | POLYAMIDE-IMIDE FILM, PREPARATION METHOD THEREOF, AND DISPLAY FRONT PLATE AND DISPLAY DEVICE COMPRISING SAME - Embodiments relate to a polyamide-imide film that has a clean appearance and transparency and is excellent in antiblocking properties, a process for preparing the same, and a display front panel and a display device comprising the same. The polyamide-imide film comprises a polyamide-imide polymer formed by polymerizing a diamine compound, a dianhydride compound, and a dicarbonyl compound; and a filler, wherein the dicarbonyl compound comprises a first dicarbonyl compound and a second dicarbonyl compound, the first dicarbonyl compound and the second dicarbonyl compound are structural isomers to each other, and the FH value of Equation 1 is 0.5 or less. | 2020-12-31 |
20200407522 | POLYAMIDE-BASED FILM, PREPARATION METHOD THEREOF, AND COVER WINDOW COMPRISING SAME - Embodiments relate to a polyamide-based film that is colorless and transparent, is excellent in mechanical properties and optical properties, has a wide angle of view by securing at least a certain level of luminance at various angles, and, in particular, has gloss characteristics similar to those of glass, a process for preparing the same, and a cover window comprising the same. The polyamide-based film comprises a polyamide-based polymer, wherein when the polyamide-based film is placed on a surface light source, light is irradiated from the surface light source, and the luminance value (L | 2020-12-31 |
20200407523 | WATER SOLUBLE FILM, PACKETS EMPLOYING THE FILM, AND METHODS OF MAKING AND USING SAME - A water-soluble film including a polyvinyl alcohol copolymer resin, a plasticizer, an anti-block filler, and a release modifier is disclosed herein. Also disclosed are related packets incorporating the film, and related methods of making and using the film and packets. | 2020-12-31 |
20200407524 | ROLL FILM, METHOD FOR PRODUCING ROLL FILM, METHOD FOR PRODUCING COPPER-CLAD LAMINATE AND METHOD FOR PRODUCING PRINTED BOARD - To provide a dielectric film which is excellent in dielectric properties and stability in the electric corrosion test and which is suitable for producing a high-precision printed board. | 2020-12-31 |
20200407525 | Porous Polymer Membranes Comprising Vertically Aligned Carbon Nanotubes, and Methods of Making and Using Same - The present invention provides in one aspect inexpensive and scalable methods of fabricating porous membranes comprising vertically aligned carbon nanotubes. | 2020-12-31 |
20200407526 | SELF SEALABLE THERMOPLASTIC POLYURETHANE FOAMED ARTICLES AND METHOD FOR FORMING SAME - A thermoplastic polyurethane foamed article has a density ranging from 0.3 to 0.8 g/cm3 measured at 25° C. and is self sealable in accordance with Section 7.9 of ASTM D1970/D1970M-11. The thermoplastic polyurethane foamed article is formed by melting and foaming a thermoplastic polyurethane composition having a durometer hardness ranging from 30A to 75D in the presence of a blowing agent. | 2020-12-31 |
20200407527 | WEB, STAMPABLE SHEET, AND EXPANSION MOLDED PRODUCT - To provide an expansion molded product not only excellent in sound absorption properties and rigidity but also resistant to tearing after bending deformation, and a web and a stampable sheet suitable for producing the expansion molded product. The presently disclosed web, stampable sheet, and expansion molded product contain a reinforcing fiber containing an inorganic fiber and an organic fiber, a thermoplastic resin, and a thermal expandable particle, where the proportion of the reinforcing fiber is 20 mass % or more and 55 mass % or less based on a total amount of the reinforcing fiber and the thermoplastic resin, the proportion of the organic fiber is 25 mass % or more and 77 mass % or less based on a total amount of the organic and inorganic fibers, the reinforcing fiber has an average length of 8 mm or more, and the organic fiber has a breaking elongation of 15% or more. | 2020-12-31 |
20200407528 | METHOD OF FORMATION OF A ROBUST NETWORK OF FOAM THROUGH DIELS-ALDER REACTION - Organosilicon polymer foams are synthesized using a Carboni-Lindsey reaction of a tetrazine with a siloxane polymer having at least one of alkenyl or alkynyl functional groups. Optionally, the reaction may also comprise a second polymer having at least one of alkenyl or alkynyl functional groups. The organosilicon polymer foams may be crosslinked thermoset foams. The foams may be flexible or rubbery. | 2020-12-31 |
20200407529 | POLYMER FOAM ARTICLES AND METHODS OF MAKING POLYMER FOAMS - Molded polymer foam articles are described as having a novel a foam structure. The polymer foam articles include a continuous polymer matrix defining a plurality of pneumatoceles therein which is present throughout the entirety of the article, including in the surface region extending 500 microns beneath the surface of the article. The surface region is further characterized as having compressed pneumatoceles. The novel foam structure is achieved even when molding polymer foam articles comprising a thickness of more than 2 cm, a volume of more than 1000 cm | 2020-12-31 |
20200407530 | METHODS FOR RECYCLING COTTON AND POLYESTER FIBERS FROM WASTE TEXTILES - Systems and methods are provided that involve a subcritical water reaction to recycle the cellulose and polyester components of waste cotton and cotton/polyester blend textiles that would otherwise be discarded or disposed of. Specifically, the disclosed methods provide for treatment of the waste textiles to produce advanced materials including cellulose and terephthalic acid (TPA) with a low environmental impact. The cellulose and TPA that are produced are of a high quality allowing for production of regenerated cellulose and regenerated polyethylene terephthalate (PET) suitable for fiber spinning and textile applications. | 2020-12-31 |
20200407531 | STRETCHABLE POLYMER THICK FILM CARBON BLACK COMPOSITION FOR WEARABLE HEATERS - A polymer thick film carbon black composition comprising 6-13 wt % conductive carbon black powder; and 87-94 wt % organic medium comprising thermoplastic polyurethane resin dissolved in an organic solvent may be used to form the resistive element of heaters in applications where significant stretching is required, particularly on substrates that can be highly elongated and, in particular, that can be used in wearable garment applications. | 2020-12-31 |
20200407532 | ETHYLENE/ALPHA-OLEFIN INTERPOLYMER COMPOSITIONS WITH IMPROVED CONTINUOUS HIGH TEMPERATURE RESISTANCE - A composition comprising at least the following components: A) one or more ethylene/alpha-olefin interpolymers, which comprise ≤3.5 wt % of a non-conjugated diene, based on the weight of the one or more ethylene/alpha-olefin interpolymers; B) an acid acceptor selected from the following: MgO, ZnO, or combination thereof. | 2020-12-31 |
20200407533 | ARTIFICIAL TURF FIBER WITH UV PROTECTION SUBSTANCES - The invention relates to a polymer-based artificial turf fiber comprising substances ( | 2020-12-31 |
20200407534 | COMPOSITE MATERIAL VIA IN-SITU POLYMERIZATION OF THERMOPLASTIC (METH)ACRYLIC RESINS AND ITS USE - The present invention relates to an article that comprising recycled thermoplastic polymeric composite material. The thermoplastic polymeric composite material is obtained by in situ polymerization of a thermoplastic resin with a fibrous material. More particularly the present invention relates to a polymeric composite material obtained by in-situ polymerization of a thermoplastic (meth)acrylic resin and a fibrous material containing long fibers and its use, a process for making such a composite material and manufactured mechanical or structured part or article comprising this polymeric composite material, especially wind turbine parts including welded parts and sports equipment. | 2020-12-31 |
20200407535 | Rubber Composition and Pneumatic Tire - The present technology provides a rubber composition having: from 30 to 50 parts by mass of carbon black having a nitrogen adsorption specific surface area of from 100 to 130 m | 2020-12-31 |
20200407536 | PRODUCTION METHOD FOR VULCANIZED RUBBER COMPOSITION - The present invention is a method for producing a vulcanized rubber composition that contains a rubber component containing a polyisoprene rubber, and a syndiotactic 1,2-polybutadiene, wherein the syndiotactic 1,2-polybutadiene and the polyisoprene rubber are kneaded at a temperature higher by 10 to 100° C. than the melting point of the syndiotactic 1,2-polybutadiene, and the resultant unvulcanized rubber composition is vulcanized at a temperature falling within a range of the melting point of the syndiotactic 1,2-polybutadiene ±15° C. The method improves the crack growth resistance of the vulcanized rubber composition. | 2020-12-31 |